Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
Autobahn races toward ph. 3 after midstage bipolar depression win
Elunetirom is designed to stimulate thyroid hormone receptors in the brain, avoiding side effects sparked by activity in the rest of the body.
Darren Incorvaia
Jun 4, 2026 11:31am
ASCO: Why Celcuity dares to dream of becoming $10B company
Jun 2, 2026 8:01am
At ASCO 2026, a ‘paradigm shift’ for a rare gut cancer looms
Jun 1, 2026 3:55pm
ASCO: Lilly's faith in Kelonia rewarded with ‘nutty’ CAR-T data
May 31, 2026 8:00am
ASCO: Lilly debuts ‘strong’ data for potential Padcev challenger
May 29, 2026 8:00am
GSK hep B drug cures one-fifth of patients in ‘major step’
May 28, 2026 4:30am
